Company intelligence / Profile preview

Responsive Arthroscopy

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Responsive Arthroscopy develops and commercializes sports medicine soft tissue repair solutions. The company received FDA 510(k) clearance for its Osprey Suture Anchor in January 2025 and entered into an exclusive commercial distribution agreement with Johnson & Johnson MedTech in November 2024 for distribution in the United States.

Therapeutic areas: OtherOrthopedicsRheumatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Johnson & Johnson MedTech: Exclusive commercial distribution agreement in the United States for sports soft tissue repair solutions in shoulder, foot and ankle procedures (November 2024)

Beyond the preview

Go deeper on Responsive Arthroscopy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Responsive Arthroscopy.

Explore the full profile